DJIA 16,982.59 22.02 0.13%
NASDAQ 4,444.91 -4.66 -0.10%
S&P 500 1,978.91 0.57 0.03%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

95.56 -0.19 (-0.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $95.56 -0.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $95.48
Previous Close $95.75
Daily Range $95.24 - $96.29
52-Week Range $58.06 - $99.74
Market Cap $22.6B
P/E Ratio -61.77
Dividend (Yield) $0.00 (0.0%)
Volume 1,178,298
Average Daily Volume 2,978,897
Current FY EPS -$2.74

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary Rss Feed

3 Things to Watch at Gilead

Hepatitis C is important, but only for two of the thee points.

Will Vertex Pharmaceuticals (VRTX) Loss be Below Estimates? - Analyst Blog

Should You Buy Vertex Pharmaceuticals (VRTX) Ahead of Earnings? - Tale of the Tape

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

Stock Market News for July 24, 2014 - Market News

Vertex Is Poised For An Earnings Breakout

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Anal

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog

Fed: Beware of social media, biotech stocks

Nasdaq 100 Movers: VRTX, MYL

Vertex Pharmaceuticals Inc Stock Upgraded (VRTX)

Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Res

Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

See More VRTX News...

VRTX's Top Competitors

VRTX $95.56 (-0.20%)
Current stock: VRTX
AMGN $122.65 (-0.15%)
Current stock: AMGN
GILD $91.46 (1.80%)
Current stock: GILD
BIIB $336.39 (0.28%)
Current stock: BIIB